Arch. Dis. Child

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in ADC Online
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Salonvaara, M
Right arrow Articles by Heinonen, K
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Salonvaara, M
Right arrow Articles by Heinonen, K
Archives of Disease in Childhood Fetal and Neonatal Edition 2003;88:F319
© 2003 Archives of Disease in Childhood Fetal and Neonatal Edition


ORIGINAL ARTICLE

Effects of gestational age and prenatal and perinatal events on the coagulation status in premature infants

M Salonvaara1, P Riikonen1, R Kekomäki2, E Vahtera2, E Mahlamäki3, P Halonen4, K Heinonen1

1 Department of Pediatrics, Kuopio University Hospital and Kuopio University, Kuopio, Finland
2 Finnish Red Cross Blood Transfusion Service, Helsinki, Finland
3 Department of Clinical Chemistry, Kuopio University Hospital
4 Computing Center, University of Kuopio

Correspondence to:
Correspondence to:
Dr Salonvaara, Department of Pediatrics, Kuopio University Hospital, POB 1777, FIN-70211 Kuopio, Finland;
marjut.salonvaara{at}kuh.fi

Objective: To study prospectively the effects of prematurity and perinatal events on the coagulation status of premature infants.

Patients and main outcome measures: Blood samples from premature infants born before 37 gestational weeks were taken for analysis of coagulation factors II, V, VII, and X and platelet count.

Results: A total of 125 premature infants, 71 boys, were studied at the median postnatal age of 40 minutes (range 12–100). The lowest median activities of coagulation factors II, V, VII, and X and the platelet count were observed, as expected, in infants (n = 21) born at 24–27 weeks gestation. Twin B (n = 14) had lower median activities of coagulation factors II, V, VII, and X than twin A. Infants with evidence of mild asphyxia (Apgar score at 5 minutes < 7 or cord pH < 7.26) had significantly (p < 0.05) lower levels of coagulation factors II, V, VII, and X and platelet counts than infants without asphyxia. Infants who were small for gestational age (SGA) had significantly (p < 0.05) lower levels of coagulation factors V and VII and platelet counts than infants of appropriate size for gestational age. Other prenatal and perinatal variables examined (sex, maternal hypertension and/or pre-eclampsia, antenatal steroid use, mode of delivery, Apgar scores) did not show any significant associations with coagulation status, which may be explained by the small number of infants studied.

Conclusions: The data strongly suggest that there are distinct differences in specific coagulation tests in different patient populations, which could assist in the identification of extremely preterm, SGA, or asphyxiated preterm infants who may be susceptible to haemorrhagic problems perinatally.


Keywords: coagulation factors; prematurity; asphyxia; small for gestational age







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
ARCH DIS CHILD FETAL NEONATAL ED ED PRACTICE
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2003 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health